Patent directory · USPTO A61K / A61P
Patents matching “The United States of America as represented by the Secretary of the Army”
225 pharma patents match "The United States of America as represented by the Secretary of the Army" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 225 pharmaceutical patents matching "The United States of America as represented by the Secretary of the Army" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 7256281
Recombinant P. falciparum merozoite protein-142 vaccine
granted -
US 7235644
Vaccine against Gram-negative bacterial infections
granted -
US 7235234
Bacterial delivery system
granted -
US 7227010
Recombinant light chains of botulinum neurotoxins and light chain fusion proteins for use in research and clinical therapy
granted -
US 7217418
Multivalent dengue virus vaccine
granted -
US 7217812
Extraneous DNA sequence that facilitates hantavirus gene expression
granted -
US 7217541
Method of making CS6 antigen vaccine for treating, preventing, or inhibiting enterotoxigenic Escherichia coli infections
granted -
US 7214787
Recombinant vaccine against botulinum neurotoxin
granted -
US 7175981
Method of diagnosing stage or aggressiveness of breast and prostate cancer based on levels of fatty acid binding proteins
granted -
US 7175845
Monoclonal antibodies against ricin toxin and methods of making and using thereof
granted -
US 7150875
Recombinant Plasmodium vivax merozoite protein-1 p42 vaccine
granted -
US 7118758
Transformed bacteria producing CS6 antigens as vaccines
granted -
US 7112332
Oral or intranasal vaccines using hydrophobic complexes having proteosomes and lipopolysaccharides
granted -
US 7094883
Monoclonal antibody which agglutinates E. coli having the CS4-CFA/I family protein
granted -
US 7090852
Venezuelan equine encephalitis virus replicon encoding marburg virus proteins
granted -
US 7084132
Artemisinins with improved stability and bioavailability for therapeutic drug development and application
granted -
US 7081529
Recombinant vaccine against botulinum neurotoxin
granted -
US 7060276
Plasmodium falciparum AMA-1 protein and uses thereof
granted -
US 7045336
Bacterial delivery system
expired -
US 7037680
Recombinant light chains of botulinum neurotoxins and light chain fusion proteins for use in research and clinical therapy
expired -
US 7037499
Adjuvant for transcutaneous immunization
expired -
US 7033608
“Burst-free” sustained release poly-(lactide/glycolide) microspheres
expired -
US 7029685
Plasmodium falciparum AMA-1 protein and uses thereof
expired -
US 7025963
Vaccine against Gram-negative bacterial infections
expired